APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosaRaymond J. Cho, Andrew P. South, Joya Sahu et al.|Science Translational Medicine|2018Cited by 132
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 ImmunotherapyCarol M. Amato, William A. Robinson|Cancers|2020Cited by 75
Interferon α-2a and Dacarbazine in MelanomaJohn M. Kirkwood, Robert J. Spiegel, Marc S. Ernstoff et al.|JNCI Journal of the National Cancer Institute|1990Cited by 47
Circulating CD8 <sup>+</sup> mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patientsVictoria M. Vorwald, Richard P. Tobin, Dana M. Davis et al.|Clinical & Translational Immunology|2022Cited by 26
Circulating CD8+ MAIT cells correlate with improved outcomes in anti-PD1 treated melanoma patientsVictoria M. Vorwald, Richard P. Tobin, Dana M. Davis et al.|medRxiv|2020Cited by 1